Last reviewed · How we verify

NCT06360692

Impact of Nipple Micropigmentation in Mastectomized Women

Not yet recruiting Last updated 11 April 2024
What this trial tests

trial in Body Image in 30 participants. Not yet recruiting.

Timeline
1 June 2024
Primary endpoint
30 October 2024
31 December 2025

Quick facts

Lead sponsorCardenal Herrera University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment30
Start date1 June 2024
Primary completion30 October 2024
Estimated completion31 December 2025

Conditions studied

Sponsor

Cardenal Herrera University

Who can join

18 and older, female only, with Body Image or Female Sexual Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a multicenter prospective descriptive case series study following a cohort. The micropigmentation/tattoo procedure will be carried out following the protocol established in each center (see annex x). The present investigation only involves measuring the impact that this technique has on the patients by collecting data in digital format before and after the CAP micropigmentation/tattoo that motivated their visit to the clinical service. CAP micropigmentation/tattooing is usually performed between 6 and 12 months after the breast reconstructive surgery has been completed, sufficient time for healing to complete and the breast to stabilize, although it can be performed from 2 months after the intervention. Nurses are responsible for performing micropigmentation/tattooing of the areola and nipple in mastectomized women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Body Image

Currently open trials in the same condition.

Other Cardenal Herrera University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06360692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing